Atlas Trials

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Clinical trial NCT06709339 · RECRUITING

Trial details

NCT number
NCT06709339
Sponsor
Association for Innovation and Biomedical Research on Light and Image
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Polypoidal Choroidal Vasculopathy
Start date
2025-08-06
Primary completion
2028-08-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.